Kinesin spindle protein (KSP) inhibitors with 2,3-fused indole scaffolds

Journal of Medicinal Chemistry

Volumn 53, Issue 13, 2010, Pages 5054-5058

  Oishi, Shinya ^a   Watanabe, Toshiaki ^a   Sawada, Jun Ichi ^b   Asai, Akira ^b   Ohno, Hiroaki ^a   Fujii, Nobutaka ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID DERIVATIVE; AZATOXIN; BETA CARBOLINE; CARBAZOLE DERIVATIVE; ELLIPTICINE; FUMITREMORGIN C; HARMAN; HARMINE; KINESIN SPINDLE PROTEIN INHIBITOR; MURRAYAFOLINE A; PROTEIN INHIBITOR; TERPENDOLE E; TRYPROSTATIN A; UNCLASSIFIED DRUG;

ARTICLE; CELL DIVISION; CELL GROWTH; MITOSIS; SPINDLE CELL; STRUCTURE ACTIVITY RELATION;

ALKALOIDS; CARBAZOLES; CELL PROLIFERATION; HELA CELLS; HUMANS; INHIBITORY CONCENTRATION 50; KINESIN; MITOSIS; MITOTIC SPINDLE APPARATUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77954331610     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm100476d     Document Type: Article

References (39)

1. Sawin, K. E.; LeGuellec, K.; Philippe, M.; Mitchison, T. J. Mitotic spindle organization by a plus-end-directed microtubule motor Nature 1992, 359, 540-543
2. Kapitein, L. C.; Peterman, E. J.; Kwok, B. H.; Kim, J. H.; Kapoor, T. M.; Schmidt, C. F. The bipolar mitotic kinesin Eg5 moves on both microtubules that it crosslinks Nature 2005, 435, 114-118
3. Tao, W.; South, V. J.; Zhang, Y.; Davide, J. P.; Farrell, L.; Kohl, N. E.; Sepp-Lorenzino, L.; Lobell, R. B. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage Cancer Cell 2005, 8, 49-59
4. Marcus, A. I.; Peters, U.; Thomas, S. L.; Garrett, S.; Zelnak, A.; Kapoor, T. M.; Giannakakou, P. Mitotic kinesin inhibitors induce mitotic arrest and cell death in Taxol-resistant and -sensitive cancer cells J. Biol. Chem. 2005, 280, 11569-11577
5. For recent reviews, see: Sarli, V.; Giannis, A. Inhibitors of mitotic kinesins: next-generation antimitotics ChemMedChem 2006, 1, 293-298
6. Jackson, J. R.; Patrick, D. R.; Dar, M. M.; Huang, P. S. Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat. Rev. Cancer 2007, 7, 107-117
7. Matsuno, K.; Sawada, J.; Asai, A. Therapeutic potential of mitotic kinesin inhibitors in cancer Expert Opin. Ther. Patents 2008, 18, 253-274
8. Sarli, V.; Giannis, A. Targeting the kinesin spindle protein: basic principles and clinical implications Clin. Cancer Res. 2008, 14, 7583-7587
9. Mayer, T. U.; Kapoor, T. M.; Haggarty, S. J; King, R. W.; Schreiber, S. L.; Mitchison, T. J. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen Science 1999, 286, 971-974
10. Nakazawa, J.; Yajima, J.; Usui, T.; Ueki, M.; Takatsuki, A.; Imoto, M.; Toyoshima, Y. Y.; Osada, H. A novel action of terpendole E on the motor activity of mitotic Kinesin Eg5 Chem. Biol. 2003, 10, 131-137
11. Huang, X. H.; Tomoda, H.; Nishida, H.; Masuma, R.; Omura, S. Terpendoles, novel ACAT inhibitors produced by Albophoma yamanashiensis. I. Production, isolation and biological properties J. Antibiot. 1995, 48, 1-4
12. X. Huang, H.; Nishida, H.; Tomoda, H.; Tabata, N.; Shiomi, K.; Yang, D. J.; Takayanagi, H.; Omura, S. Terpendoles, novel ACAT inhibitors produced by Albophoma yamanashiensis. II. Structure elucidation of terpendoles A, B, C and D J. Antibiot. 1995, 48, 5-11
13. Hotha, S.; Yarrow, J. C.; Yang, J. G.; Garrett, S.; Renduchintala, K. V.; Mayer, T. U.; Kapoor, T. M. HR22C16: a potent small-molecule probe for the dynamics of cell division Angew. Chem., Int. Ed. 2003, 42, 2379-2382
14. Okumura, H.; Nakazawa, J.; Tsuganezawa, K.; Usui, T.; Osada, H.; Matsumoto, T.; Tanaka, A.; Yokoyama, S. Phenothiazine and carbazole-related compounds inhibit mitotic kinesin Eg5 and trigger apoptosis in transformed culture cells Toxicol. Lett. 2006, 166, 44-52
15. For patent information including the related carbazole compounds, see: Dhanak, D.; Knight, S. D.; Moore, M. L.; Newlander, K. A. PCT Int. Appl. WO2006005063, 2006.
16. Similar scaffold identification approaches for other target molecules have been reported, see: Koch, M. A.; Schuffenhauer, A.; Scheck, M.; Wetzel, S.; Casaulta, M.; Odermatt, A.; Ertl, P.; Waldmann, H. Charting biologically relevant chemical space: a structural classification of natural products (SCONP) Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 17272-17277
17. Nören-Müller, A.; Reis-Corrẽa, I., Jr.; Prinz, H.; Rosenbaum, C.; Saxena, K.; Schwalbe, H. J.; Vestweber, D.; Cagna, G.; Schunk, S.; Schwarz, O.; Schiewe, H.; Waldmann, H. Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 10606-10611
18. Reis-Corrẽa, I., Jr.; Nören-Müller, A.; Ambrosi, H. D.; Jakupovic, S.; Saxena, K.; Schwalbe, H.; Kaiser, M.; Waldmann, H. Identification of inhibitors for mycobacterial protein tyrosine phosphatase B (MptpB) by biology-oriented synthesis (BIOS) Chem. Asian J. 2007, 2, 1109-1126
19. Nören-Müller, A.; Wilk, W.; Saxena, K.; Schwalbe, H.; Kaiser, M.; Waldmann, H. Discovery of a new class of inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B by biology-oriented synthesis Angew. Chem., Int. Ed. 2008, 47, 5973-5977
20. Alternative nonindole based KSP inhibitors have been reported, for example: Brier, S.; Lemaire, D.; Debonis, S.; Forest, E.; Kozielski, F. Identification of the protein binding region of S -trityl- l -cysteine, a new potent inhibitor of the mitotic kinesin Eg5 Biochemistry 2004, 43, 13072-13082
21. Gartner, M.; Sunder-Plassmann, N.; Seiler, J.; Utz, M.; Vernos, I.; Surrey, T.; Giannis, A. Development and biological evaluation of potent and specific inhibitors of mitotic Kinesin Eg5 ChemBioChem 2005, 6, 1173-1177 (Pubitemid 40978175)
22. Watanabe, T.; Ueda, S.; Inuki, S.; Oishi, S.; Fujii, N.; Ohno, H. One-pot synthesis of carbazoles by palladium-catalyzed N -arylation and oxidative coupling Chem. Commun. 2007, 4516-4518
23. Watanabe, T.; Oishi, S.; Fujii, N.; Ohno, H. Palladium-catalyzed direct synthesis of carbazoles via one-pot N -arylation and oxidative biaryl coupling: synthesis and mechanistic study J. Org. Chem. 2009, 74, 4720-4726
24. Forbes, E. J.; Stacey, M.; Tatlow, J. C.; Wragg, R. T. The synthesis of 1-, 2- and 3-trifluoromethylcarbazoles by the Fischer-indole method Tetrahedron 1960, 8, 67-72
25. Ohta, T.; Miyake, S.; Shudo, K. A trifluoromethanesulfonic acid-catalyzed reaction of arylhydrazines with benzene Tetrahedron Lett. 1985, 26, 5811-5814
26. Jash, S. S.; Biswas, G. K.; Bhattacharyya, S. K.; Bhattacharyya, P.; Chakraborty, A.; Chowdhury, B. K. Carbazole alkaloids from Glycosmis pentaphylla Phytochemistry 1992, 31, 2503-2505
27. Leteurtre, F.; Madalengoitia, J.; Orr, A.; Guzi, T. J.; Lehnert, E.; Macdonald, T.; Pommier, Y. Rational design and molecular effects of a new topoisomerase II inhibitor, azatoxin Cancer Res. 1992, 52, 4478-4483
28. Molina, P.; Fresneda, P. M.; Almendros, P. Fused carbazoles by tandem Aza Wittig/electrocyclic ring closure. Preparation of 6 H -pyrido[4,3- b ]carbazole, 11 H -pyrido[4,3- a ]carbazole and 11 H -pyrido[3,4- a ]carbazole derivatives Tetrahedron 1993, 49, 1223-1236
29. Fabien, D.; Gilbert, K. Efficient synthesis of 1,2,3,4-tetrahydro-11 H -benzo[ a ]carbazole and its regioselective oxidation Synlett 2006, 7, 1021-1022
30. Hu, L.; Li, Z. R.; Li, Y.; Qu, J.; Ling, Y. H.; Jiang, J. D.; Boykin, D. W. Synthesis and structure-activity relationships of carbazole sulfonamides as a novel class of antimitotic agents against solid tumors J. Med. Chem. 2006, 49, 6273-6282
31. Sanz, R.; Escribano, J.; Pedrosa, M. R.; Aguado, R.; Arnaiz, F. J. Dioxomolybdenum(VI)-catalyzed reductive cyclization of nitroaromatics: synthesis of carbazoles and indoles Adv. Synth. Catal. 2007, 349, 713-718
32. Hadjaz, F.; Yous, S.; Lebegue, N.; Berthelot, P.; Carato, P. A mild and efficient route to 2-benzyl tryptamine derivatives via ring-opening of β-carbolines Tetrahedron 2008, 64, 10004-10008
33. Goodwin, S.; Smith, A. F.; Horning, E. C. Alkaloids of Ochrosia elliptica Labill J. Am. Chem. Soc. 1959, 81, 1903-1908
34. Cui, C. B.; Kakeya, H.; Okada, G.; Onose, R.; Osada, H. Novel mammalian cell cycle inhibitors, tryprostatins A, B and other diketopiperazines produced by Aspergillus fumigatus. I. Taxonomy, fermentation, isolation and biological properties J. Antibiot. 1996, 49, 527-533 (Pubitemid 26235660)
35. Cui, C. B.; Yan, S. Y.; Cai, B.; Yao, X. S. Carbazole alkaloids as new cell cycle inhibitor and apoptosis inducers from Clausena dunniana Levl J. Asian Nat. Prod. Res. 2002, 4, 233-241
36. Funayama, Y.; Nishio, K.; Wakabayashi, K.; Nagao, M.; Shimoi, K.; Ohira, T.; Hasegawa, S.; Saijo, N. Effects of β- and γ-carboline derivatives of DNA topoisomerase activities Mutat. Res. 1996, 349, 183-191
37. Cao, R.; Peng, W.; Chen, H.; Ma, Y.; Liu, X.; Hou, X.; Guan, H.; Xu, A. DNA binding properties of 9-substituted harmine derivatives Biochem. Biophys. Res. Commun. 2005, 338, 1557-1563
38. Carbazoles 8e, f and 9e apparently activated the topoisomerase II-mediated relaxation. This activity was not due to the direct DNA relaxation by the compounds (see the Supporting Information).
39. The reason of the unprecedented phenotype observed remains unsolved.